Merck & Co., Inc. news

   Watch this stock
Showing stories 1 - 10 of about 158   

Articles published

MRK 54.02 0.00 (0.00%)
price chart
A Quick Look at Merck & Co. Inc.'s Drug Development Pipeline
Today, I'd suggest we take a closer look at Merck's (NYSE: MRK ) drug development pipeline in order to get a better idea of how well the company is preparing for its future beyond patent expirations, as well as note which handful of developing drugs ...
Related articles »  
Bayer closes acquisition of consumer care business of Merck & Co., Inc. for ...
Bayer has completed the global acquisition of the consumer care business of the U.S. pharmaceuticals group Merck & Co., Inc., Whitehouse Station, New Jersey. The transaction closed on October 1, 2014, following receipt of required antitrust approvals.
Company Update: Merck & Co Inc (NYSE:MRK) - Merck Completes Sale of ...  Jutia Group
Related articles »  
Better Dividend Stock: Merck & Co. Inc. or Bristol-Myers Squibb Co.?
Dividend stocks are arguably the most critical component to the success of any long-term investor. According to the latest statistics from FactSet, S&P 500 companies paid out a whopping $91.5 billion in dividends during the second quarter, or an ...
Related articles »  
Merck & Co., Inc. (MRK), The Walt Disney Company (DIS), The Boeing Company ...
Abner Herrman & Brock owns 265,643 shares of Merck & Co., Inc. (NYSE:MRK) with net market value of $15.7 million. The drug manufacturer sold its consumer care unit, Merck Consumer Care, for $14.2 billion to Bayer AG.
Merck Still Looks Very Expensive (MRK)
Oct. 14, 2014 3:02 PM ET | About: Merck & Co Inc. (MRK) by: Stock Traders Daily ... Earnings growth was dismal prior to the recent quarter, but because the comps from the second quarter of 2012 were no longer in the equation the trailing 12 month ...
Valuation analysis for Merck & Co., Inc. (NYSE:MRK)  Stock Traders Daily
Related articles »  
Ragwitek by Merck & Co, Inc, and Catalent Pharma
The FDA has approved sublingual Ragwitek (Short Ragweed Pollen Allergen Extract) tablets as an immunotherapy option for selected patients with confirmed ragweed pollen�induced allergic rhinitis.
Related articles »  
The 4 DJIA Stocks Sank the Market
The drug maker was hit by news of a successful trial of a competitor's treatment for a rare nervous system disorder. Merck's volume was about 30% above the daily average of around 8.4 million shares. The Walt Disney Co. (NYSE: DIS) traded down 2.32% at ...
Merck & Co. Inc. (MRK) Among Biggest DJIA Losers on October 13
Dow Jones (DJIA) Today: Merck (MRK) Lower
Related articles »  
Merck & Co., Inc. Stock Still Holding Its Position As A Big-Pharma Leader
Merck & Co. (NYSE: MRK) is the perfect example of a go-to �safe harbor� stock when market conditions turn bearish, as they did last Thursday and early Monday morning.
Related articles »  
Merck & Co., Inc. (NYSE:MRK) Would Payout $31 Million Toward Organon ...
Merck & Co., Inc. (NYSE:MRK) reported that its subsidiary, Organon USA Inc., has agreed for claims settlement, resolving the issue of overcharging for its Remeron antidepressant drug.
State Highlights: Merck To Pay $31 Million To Settle States' Medicaid ...
Related articles »  
Stocks Alert - Merck & Co., Inc. (NYSE:MRK),JPMorgan Chase & Co. (NYSE:JPM ...
Houston, TX - Oct 20, 2014 - (Techsonian) - Merck & Co., Inc. (NYSE:MRK) released the final outcome of the earlier declared offers to purchase (collectively, the �Offers�) any and all of the outstanding notes listed in the table below (collectively ...